Bioethics Stock Analysis

Bioethics Pink Sheet Analysis Notes

About 89.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.09. Bioethics last dividend was issued on the 2nd of November 2020. The entity had 1:10 split on the 2nd of November 2020. It intends to seek, investigate, and if warranted acquire an interest in a business opportunity. The company was incorporated in 1990 and is based in Ogden, Utah. Bioethics is traded on OTC Exchange in the United States.The quote for Bioethics is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Bioethics please contact Mark Scharmann at 801 399 3632.

Bioethics Investment Alerts

Bioethics Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 295.15 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bioethics's market, we take the total number of its shares issued and multiply it by Bioethics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 17th of January 2026, Bioethics shows the Mean Deviation of 3.16, standard deviation of 12.65, and Risk Adjusted Performance of (0.08). Bioethics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Bioethics Price Movement Analysis

Bioethics Outstanding Bonds

Bioethics Predictive Daily Indicators

Bioethics Forecast Models

Bioethics' time-series forecasting models are one of many Bioethics' pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bioethics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Bioethics Debt to Cash Allocation

Bioethics currently holds 398.53 K in liabilities. Debt can assist Bioethics until it has trouble settling it off, either with new capital or with free cash flow. So, Bioethics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bioethics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bioethics to invest in growth at high rates of return. When we think about Bioethics' use of debt, we should always consider it together with cash and equity.

Bioethics Assets Financed by Debt

Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Bioethics' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Bioethics, which in turn will lower the firm's financial flexibility.

Bioethics Corporate Bonds Issued

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Bioethics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bioethics shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Bioethics. By using and applying Bioethics Pink Sheet analysis, traders can create a robust methodology for identifying Bioethics entry and exit points for their positions.

When running Bioethics' price analysis, check to measure Bioethics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioethics is operating at the current time. Most of Bioethics' value examination focuses on studying past and present price action to predict the probability of Bioethics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioethics' price. Additionally, you may evaluate how the addition of Bioethics to your portfolios can decrease your overall portfolio volatility.